NEW YORK and MUMBAI, India, Oct. 7, 2019 /PRNewswire/ -- Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been named a Leader in the Everest Group PEAK Matrix™ for Life Sciences Digital Services1.

VANCOUVER, Oct. 7, 2019 /PRNewswire/ - Agrios Global Holdings Ltd. (CSE: AGRO) 

JERUSALEM, Oct. 7, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a phase 3 clinical stage biopharmaceutical company focused on developing and commercializing the M-001 clinical Phase 3 Universal Influenza Vaccine candidate, announced today the receipt of €4 million from the European Investment Bank (EIB). These funds are the final tranche of the

MINNEAPOLIS, Oct. 7, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of immunohistochemistry (IHC) antibodies using the Advanced Cell Diagnostics™-branded RNAscope in situ hybridizati

NESS-ZIONA, Israel, Oct. 7, 2019 /PRNewswire/ -- Tikcro Technologies Ltd. (OTCQB: TIKRF), a pre-clinical stage developer of antibodies for cancer immune-therapy, today reported its financial results for the second quarter ended June 30, 2019."We continue to pursue the development of a new cytotoxic T l

CHICAGO, LONDON and TORONTO, Oct. 7, 2019 /PRNewswire/ -- RLDatix, a leading provider of governance, risk and compliance (GRC) solutions that drive patient safety, quality improvement, and harm reduction in healthcare, announced today the acquisition of Milpitas, Calif., based Quantros Inc.'s patient safety business.

DELAFIELD, Wis., Oct. 7, 2019 /PRNewswire/ -- Run the World for Mental Health, the first worldwide virtual 5K, is set for October 10, World Mental Health Day, in support of those with mental health illnesses. Runners from across the globe will complete a 5K from their own locat

SAN FRANCISCO, Oct. 7, 2019 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced the initiation of two Phase 1b studies of NKTR-358 (LY3471851*), a novel T regulatory (Treg) cell stimulator, one in patients with psoriasis and one in patients with atopic dermatitis. NKTR-358 is designed to treat autoimmune and inflammatory condi

ANNAPOLIS, Md., Oct. 7, 2019 /PRNewswire/ -- Today, Plasma Protein Therapeutics Association (PPTA) in conjunction with its member companies, launched their seventh annual International Plasma Awareness Week (IPAW), held October 7-11. IPAW is a globally recognized week designed to:Raise awareness of plasma collection.

PALO ALTO, Calif., Oct. 7, 2019 /PRNewswire/ -- Bia-Echo Foundation, the recently launched private foundation established by Nicole Shanahan, today announce